The Outstanding Investigator Award is presented annually to an outstanding investigator age 45 or younger in recognition of excellence in biomedical research.
Epstein's research interest, along with the Epstein laboratory at PENN, is in molecular mechanisms of cardiovascular development, and the implications of these mechanisms for understanding human disease. His lab works with transgenic and knockout mouse models.
Epstein, who is also a board certified cardiologist, is receiving a $5,000 award from the AFMR, dedicated to fostering medical research and support programs aimed at developing the careers of physician scientists.
Editor's Notes:
For more information on Dr. Jon Epstein and his research, go on-line to:
www.uphs.upenn.edu/mcrc/epstein
To view past AFMR award winners, go on-line to: www.afmr.org/awards_OIA_Recipients.cgi
PENN Medicine is a $2.7 billion enterprise dedicated to the related missions of medical education, biomedical research, and high-quality patient care. PENN Medicine consists of the University of Pennsylvania School of Medicine (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System.
Penn's School of Medicine is ranked #2 in the nation for receipt of NIH research funds; and ranked #4 in the nation in U.S. News & World Report's most recent ranking of top research-oriented medical schools. Supporting 1,400 fulltime faculty and 700 students, the School of Medicine is recognized worldwide for its superior education and training of the next generation of physician-scientists and leaders of academic medicine.
The University of Pennsylvania Health System includes three hospitals [Hospital of the University of Pennsylvania, which is consistently ranked one of the nation's few "Honor Roll" hospitals by U.S. News & World Report; Pennsylvania Hospital, the nation's first hospital; and Penn Presbyterian Medical Center]; a faculty practice plan; a primary-care provider network; two multispecialty satellite facilities; and home care and hospice.